4//SEC Filing
BIOCRYST PHARMACEUTICALS INC 4
Accession 0000882796-03-000004
$BCRXCIK 0000882796operating
Filed
Oct 27, 7:00 PM ET
Accepted
Oct 28, 3:55 PM ET
Size
7.6 KB
Accession
0000882796-03-000004
Insider Transaction Report
Form 4
BUGG CHARLES E
DirectorChairman
Transactions
- Exercise/Conversion
Common Stock
2003-10-24$6.00/sh+10,000$60,000→ 44,035 total - Disposition to Issuer
Stock Option
2003-10-24$2.85/sh−170,000$484,500→ 10,000 totalExercise: $6.00From: 1994-03-02Exp: 2003-11-18→ Common Stock (170,000 underlying) - Exercise/Conversion
Stock Option
2003-10-24$6.00/sh−10,000$60,000→ 0 totalExercise: $6.00From: 1994-03-02Exp: 2003-11-18→ Common Stock (10,000 underlying)
Holdings
- 73,138(indirect: By Partnership)
Common Stock
Footnotes (1)
- [F1]The option was canceled by mutual agreement of the reporting person and BioCryst Pharmaceuticals, Inc.. The reporting person received $484,500.00 as consideration for the cancellation.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882796
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 7:00 PM ET
- Accepted
- Oct 28, 3:55 PM ET
- Size
- 7.6 KB